惠斯安普HRA品牌怎么样 申请店铺

我要投票 惠斯安普HRA在医疗器械行业中的票数:188 更新时间:2025-02-24
惠斯安普HRA是哪个国家的品牌?「惠斯安普HRA」是 秦皇岛市惠斯安普医学系统股份有限公司 旗下著名品牌。该品牌发源于河北省秦皇岛市,由创始人陈董在2011年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力惠斯安普HRA品牌出海!通过在本页面挂载惠斯安普HRA品牌的产品链接和联系邮箱,可以提高惠斯安普HRA产品曝光!跨境电商爆单神器,目前只要100元/年哦~

惠斯安普HRA怎么样

秦皇岛市惠斯安普医学系统股份有限公司,成立于2011年,是一家专注于生物医学领域医疗设备及系统的设计、开发、生产及销售为一体的企业。公司拥有生物医学领域的博士、硕士专业研发人才50余名;与国内外多家生物医学研究机构、高等院校和医院建立了稳定的合作关系,并设有电磁干扰与静电防护院士工作站、生物医学研究中心和生物医学体验中心。

惠斯安普医学系统股份有限公司紧密围绕国家“战略前移,重心下移”的人口与健康科技发展战略方针,努力在国民健康管理产业发展中开拓自己的成长空间,先后研制成功HRA疾病早期筛查及健康风险评估、ADDS阿尔茨海默病早期筛查及诊断、ADTS记忆力障碍训练系统、PMR脉冲磁共振微循环修复等“全链式”健康管理适宜技术设备,构建了覆盖“医院前“和”医院后”细分市场的疾病早期筛查评估、健康风险干预、功能康复全产品线。

目前,惠斯安普产品用户已遍及国内32个省、市、区。惠斯安普医学系统股份有限公司已与中国健康促进基金会、清华大学、北京大学结成战略合作伙伴关系,在国内联合开展以HRA应用研究和国民健康云数据计划为核心内容的健康管理工程,加速了HRA在国家健康管理示范基地及其旗舰单位、高校和体育运动系统的推广,使更广大的人群从中受益。

发展历程:

2011年

4月 惠斯安普医学公司正式成立;

7月 受邀参展由国家科技部参加了国家十一五重大科技成果展;

2013年

5月 HRA健康风险评估设备取得中华人民共和国医疗器械注册证;

7月 HRA健康风险评估设备参加澳门科技周活动;

2014年

4月 惠斯安普公司与清华大学联合发起的国民“健康云数据”计划正式启动;

11月 中国高校师生健康促进联盟在京成立,HRA成为国内高校师生健康数据釆集专用设备;

2015年

3月 惠斯安普成为中国人民解放军总后勤部物资采购供应商;

4月 惠斯安普与中国健康促进基金会合作的“HRA多中心应用研究项目”正式启动;

2016年

8月 惠斯安普公司正式挂牌新三板,股票代码838857;

2017年

1月 HRA健康风险评估快速体检车在秦皇岛惠斯安普下线;

9月 惠斯安普获批成立省级科技专家企业工作站;

2018年

10月 惠斯安普与阿里健康签署战略合作协议,共同开启“应用人工智能黑科技HRA,开展区域人群健康风险评估管理”计划。


Qinhuangdao Huisi Anpu Medical System Co., Ltd., founded in 2011, is an enterprise focusing on the design, development, production and sales of medical equipment and systems in the biomedical field. The company has more than 50 doctoral and master's R & D talents in biomedical field. It has established stable cooperation with many biomedical research institutions, colleges and hospitals at home and abroad, and has academician workstation for electromagnetic interference and electrostatic protection, biomedical research center and biomedical experience center. Based on the national strategy of population and health science and technology development, wisanpu Medical System Co., Ltd. strives to develop its own growth space in the development of national health management industry. It has successively developed the Department of early screening and health risk assessment of HRA disease, early screening and diagnosis of Alzheimer's disease, and training of ADTs memory impairment The "whole chain" health management appropriate technology and equipment, such as unifying and PMR pulse magnetic resonance microcirculation repair, has constructed the whole product line of disease early screening assessment, health risk intervention and functional rehabilitation covering the "pre hospital" and "post hospital" market segments. At present, the products of wisanp have been used in 32 provinces, cities and districts in China. Wisanpu Medical System Co., Ltd. has formed strategic partnership with China health promotion foundation, Tsinghua University and Peking University to jointly carry out the health management project with HRA application research and national health cloud data plan as the core content in China, accelerating the promotion of HRA in the national health management demonstration base and its flagship units, universities and sports systems To benefit the wider population. Development history: in April 2011, wisanp medical company was officially established; in July, it was invited to participate in the national 11th five year major scientific and technological achievements exhibition by the Ministry of science and technology of the people's Republic of China; in May 2013, HRA health risk assessment equipment obtained the registration certificate of medical devices of the people's Republic of China; in July, HRA health risk assessment equipment participated in Macao science and technology week; in April 2014, wisanp medical company and Tsinghua University jointly participated The national "health cloud data" plan launched officially; in November, the health promotion alliance of teachers and students of Chinese universities was established in Beijing, HRA has become a special equipment for health data collection of teachers and students in Colleges and universities in China; in March 2015, Huis amp became a material procurement supplier of the General Logistics Department of the people's Liberation Army; in April, the "HRA multi center application research project" cooperated by Huis amp and China health promotion foundation was officially launched; in August 2016, Huis amp officially launched the new third board, Stock Code: 838857; in January 2017, the HRA health risk assessment rapid physical examination vehicle was offline in Huisi Anpu, Qinhuangdao; in September, Huisi Anpu was approved to establish a provincial science and technology expert enterprise workstation; in October 2018, Huisi Anpu and Ali health signed a strategic cooperation agreement to jointly launch the plan of "applying human industry intelligent black technology HRA to carry out regional population health risk assessment management".

本文链接: https://brand.waitui.com/1b66b8b94.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

深圳:近期将发布人形机器人专项政策 在全市科技重大专项中安排人工智能和机器人专项

深圳市政府新闻办2月23日召开“打造最好科技创新生态和人才发展环境”主题新闻发布会。市人工智能产业办主任林毅在会上表示,深圳在人工智能和机器人领域基础雄厚、未来可期。下一步,我们将在政策、场景、创新、机器人四个方面持续发力。此外,近期我们还将发布人形机器人专项政策,通过“揭榜挂帅”等方式,对开放应用场景、突破关键技术、构建专用数据集、提升规模化制造和应用能力等予以精准支持。同时,还将在全市科技重大专项中安排人工智能和机器人专项,鼓励产、学、研、用组成创新联合体进行协同攻关。(财联社)

18分钟前

一汽大众ID.系列部分车型官降至高5.5万元

一汽-大众宣布对旗下ID.系列部分车型进行降价,最高降幅达5.5万元。此次降价活动涉及ID.4 CROZZ和ID.6 CROZZ两款车型,无门槛一口价分别为13.99万元和19.59万元起,还可叠加官方置换补贴至高1万元、国家置换补贴至高2万元。(财联社)

18分钟前

2025年中央一号文件发布

36氪获悉,2025年中央一号文件2月23日发布,《中共中央 国务院关于进一步深化农村改革 扎实推进乡村全面振兴的意见》提出,以改革开放和科技创新为动力,巩固和完善农村基本经营制度,深入学习运用“千万工程”经验,确保国家粮食安全,确保不发生规模性返贫致贫,提升乡村产业发展水平、乡村建设水平、乡村治理水平,千方百计推动农业增效益、农村增活力、农民增收入,为推进中国式现代化提供基础支撑,这是党的十八大以来第13个指导“三农”工作的中央一号文件。

18分钟前

海天味业:公司发行H股备案申请材料获中国证监会接收

36氪获悉,海天味业公告称,公司已于2025年1月13日向香港联交所递交了发行H股股票并在香港联交所主板挂牌上市的申请。公司已向中国证监会报送了关于公司本次发行的备案申请材料并于近日获中国证监会接收。该事项仍存在不确定性,公司将根据进展情况及时履行信息披露义务。

18分钟前

山河药辅:股东复星医药拟减持不超过3%公司股份

36氪获悉,山河药辅发布公告,股东上海复星医药产业发展有限公司因经营需要,计划以集中竞价和大宗交易方式合计减持公司股份不超过697.8万股,即不超过公司总股本的3%。

18分钟前

本页详细列出关于海氏海诺的品牌信息,含品牌所属公司介绍,海氏海诺所处行业的品牌地位及优势。
咨询